Mitochondrial electron transport has a central role in regulating energy supply within a cell. We hypothesized that mitochondrial variants or increased levels of mitochondrial heteroplasmy could be associated with common childhood obesity through their effects on mitochondrial function. To investigate this question, we queried two genome-wide genotyped childhood obesity datasets, consisting of 1080 European-American (EA) obese children (defined as BMIX95th percentile) together with 2500 EA lean controls (defined as BMIo50th percentile) and 1479 African-American (AA) obese children and 1575 AA lean controls. Association was not observed between childhood obesity and any of the assayed mitochondrial polymorphisms in either ethnicity. We also found no observable differences in heteroplasmy between each obese and non-obese group. Finally, we analyzed the quantitative mitochondrial genotype cells generated, whether they exceeded the heteroplasmy threshold or not. With this more lenient test, we found six positions with a significant difference between EA cases and controls (Po1 Â 10 À4 ). However, when evaluating the AA data set, no differences were noted at these sites, suggesting that our initial observations were because of chance rather than a meaningful relationship to childhood obesity. As such, it is unlikely that common mitochondrial polymorphisms or heteroplasmy have a role in childhood obesity.
Introduction
In the past 5 years, genome-wide association studies have had an important role in uncovering genetic determinants contributing to the pathogenesis of obesity; however, such discoveries explain little of the predicted genetic component. Mitochondrial DNA provides a seldom-explored alternative for inheritance of disease susceptibility. The mitochondrion has a prominent role in the disposition of consumed calories and energy homeostasis. The identification of families with a matrilineal inheritance of obesity and specific mutations in mitochondrial DNA has provided evidence for such a possibility. 1 -3 Changes in mitochondrial sequence may influence obesity by tightly coupling mitochondrial electron transport, or by interfering with mitochondrial function with subsequent diversion of dietary energy sources towards fat synthesis. 4 Studies of mitochondrial haplogroups, clusters of haplotypes emerging along ancient patterns of human migration, have also suggested a role for sequence variation in environmental adaptations. 5 Conversely, obesity has been widely demonstrated to interfere with mitochondrial function. 6 Observed effects include defects in mitochondrial localization, alterations in the activities of electron transport chain and changes in the level of mitochondrial DNA . These effects are generally viewed as a secondary impact of obesity upon mitochondrial function, rather than the primary alteration suggested for inherited sequence variation. The mitochondrial genome may be unusually sensitive to the interaction between sequence and environment. It is subject to uniparental inheritance, has distinct copy-control rules and recombination-based repair does not occur. The introduction of mutations gives rise to the state of heteroplasmy, the presence of multiple distinct species within an organism, tissue or cell. Heteroplasmy is a unique property of mitochondrial DNA, often expressed as the percentage (or load) of minor-allele or mutation-bearing genomes that are present. We have recently determined that single nucleotide protein (SNP) genotyping arrays can accurately assay mitochondrial heteroplasmy. 7 We utilized genome-wide genotyping data 8 to determine the potential relationship between mitochondrial heteroplasmy and common mitochondrial polymorphisms in the pathogenesis of childhood obesity.
Participants and methods

Research subjects
Our study consisted of 1080 European-American (EA) obese children (defined as BMIX95th percentile), 2500 EA lean controls (defined as BMIo50th percentile), 1479 AfricanAmerican (AA) obese children and 1575 AA lean controls (2 -18 years) that met strictly established data quality thresholds, as described previously. 8 We elected to use the EA group as the discovery set, as there was a greater excess of controls. All subjects were consecutively recruited from the Greater Philadelphia area from 2006 to 2011 through the Center for Applied Genomics at the Children's Hospital of Philadelphia and were biologically unrelated. This study was approved by the Institutional Review Board of the Children's Hospital of Philadelphia. Self-reported ethnicity was confirmed by multidimensional scaling methodologies. BMIX95th percentile was defined using the Center for Disease Control z-score ¼ 1.645 (http://www.cdc.gov/nchs/ about/major/nhanes/growthcharts/datafiles.htm). However, all subjects had to be between À3 and þ 3 s.d. of the Center for Disease Control-corrected BMI in order to exclude outliers that could potentially be a result of measurement error or severe obesity. We carefully reviewed the phenotypes of our controls to remove anyone with a syndrome, multi-systemic disorder or developmental delay.
Genotyping
We performed high throughput genome-wide SNP genotyping using the Illumina Infinium II BeadChip technology, as previously described. 9 For the analysis of heteroplasmy, we restricted our analysis to individuals assayed on the HumanHap610 platform (487 EA cases and 1091 EA controls; replication group 582 AA cases and 587 AA controls). The SNPs represented on this Illumina platform were previously selected based on their minor allele frequency in various populations. None of these SNPs have been directly implicated in mitochondrial pathologies previously 10 (Supplementary Table 1 ).
Extraction and analysis of mitochondrial data
Mitochondrial sequence data was exported in to MatLab (MathWorks, Natick, MA, USA). Data processing to eliminate low-quality calls and to determine the threshold for heteroplasmy at each position was performed as previously described. 7 We studied the relationship between SNP genotype and obesity using sequential w 2 analysis. Differences in heteroplasmy were detected by two complimentary methods. Briefly, the expected and observed frequencies of individuals exceeding the heteroplasmy threshold in the obese and non-obese groups at each position were compared using a w 2 -test. Thresholds for heteroplasmy were the greater of 5.4% heteroplasmy or 5 s.d. above the mean of the genotype values at each SNP. We also analyzed differences between the genotype values in both groups using an unpaired, homoscedastic t-test. Measures of significance were Bonferroni corrected.
Results
Genotype analysis
We evaluated each mitochondrial SNP for association with pediatric obesity status. Within our EA discovery cohort, the average minor allele frequency was 3.6%; 80 of the SNPs had minor allele frequencies 41% and 2 of the alleles were not present in either the case or control populations (Supplementary Figure 1) ; however, no association was observed between genotype and childhood obesity for any of the 138 SNPs (Supplementary Table 2 ). Analysis of SNP genotype in the AA replication cohort also yielded no significant differences between obese and non-obese children.
Heteroplasmy-based analysis of obesity We next evaluated whether heteroplasmy was more frequently observed in obese or lean groups. This effect could be seen if mitochondrial stress, induced by the obese state, led to poor mitochondrial replicative fidelity at earlier ages. Alternatively, heteroplasmy could interfere with mitochondrial function and serve as a pre-disposing factor for childhood obesity.
We evaluated heteroplasmy using two complimentary analyses. First, we set a cutoff for heteroplasmy based upon the genotype values of each cohort. This helped to identify individuals whose genotyped value was 45 s.d. from the population and had at least 5% representation of both alleles by mitochondrial sequencing. We then asked whether there was an excess of heteroplasmy in the obese or lean-mass groups. Using this metric on the EA data set, we found no observable differences. Again, using the AA data set for confirmation, we observed no differences in heteroplasmy between the case and control groups.
Our second metric analyzed the quantitative genotype calls generated from the array regardless of whether they exceeded any particular threshold. This more lenient test Mitochondrial heteroplasmy and childhood obesity SFA Grant et al would allow the inclusion of smaller variance from homoplasmy at the cost of a potentially higher false-positive detection rate. In the evaluation of the EA group, we observed several positions with a significant difference between cases and controls. However, these reflected a slight increase in heteroplasmy in the non-obese group, contrary to our hypothesis (Table 1) . When these same positions were evaluated in the AA data set, there were no differences noted, suggesting no consistent relationship with obesity.
Confirmation of haplogroup-based signatures
To confirm that the mitochondrial SNP genotyping could in fact detect other relevant known differences within our data set, we compared mitochondrial SNP genotypes for individuals who had self-identified themselves as being of African or European descent. Differences between the EA and AA groups were readily apparent at multiple positions and for 102/138 (74%) of mitochondrial SNPs evaluated these reached significance (Table 2) . A number of the most highly skewed SNPs mark major haplogroup branchpoints, such as 3594T that divides the African L0, L1 and L2 haplogroups from other African and non-African haplogroups. Indeed, the only arrayed haplogroup-associated SNPs not different between EA and AA populations delineated two East Indian haplogroups, which would not be predicted to have distinct ratios. This confirms that detectable differences in SNP frequencies can be observed using an array-based approach.
Discussion
The contribution of mitochondrial genotype and heteroplasmy to pediatric obesity has not been previously fully Abbreviations: AA, African Americans; EA, European Americans; SNP, single nucleotide polymorphism. SNPs are listed with the number of individuals genotyped for each allele. The P-value is from a w 2 analysis of the hypothesis that SNP variation is equally distributed in the discovery (EA) and replication (AA) groups. Many of the SNPs, where allele frequencies differ significantly different between the groups, are haplogroup defining; these associations are listed with the relevant haplogroup on the right. Abbreviations: AA, African Americans; EA, European Americans; SNP, single-nucleotide polymorphism. The mean and s.d. for genotype at each position were determined in obese and lean children. A value of zero represents homoplasmy. There was a modest, but statistically significant difference between genotype observed in the discovery population of European-American children at six of the SNPs. In each case, the association was reversed from that predicted by a hypothesis that increased obesity is associated with greater heteroplasmy. None of these associations were noted in the replication set. P-values were calculated by Student's t-test and corrected for multiple testing.
Mitochondrial heteroplasmy and childhood obesity SFA Grant et al examined. We have analyzed the influence of mitochondrial genetics on common childhood obesity using SNP arraygenerated data. Models using mitochondrial SNP data have suggested a striking similarity in the power to detect nuclear and mitochondrial variants and disease association; 11 however, our results for childhood obesity are clearly negative. Although a recent study in adults detected association with two common mitochondrial polymorphisms and body fat mass, 12 other attempts to link mitochondrial SNPs to logically related disorders, including type 2 diabetes 13 and ischemic stroke, 14 have failed to identify such associations. It is possible that characteristics of the mitochondrial genome (little or no recombination and uniparental inheritance) limit the applicability of the association approach to genetic discovery within mitochondrial DNA. There are some caveats in our study design. First, we have used DNA samples derived from blood rather than from other tissue more directly implicated in obesity, including the muscle and adipocytes, thus potentially confounding our ability to detect heteroplasmy secondary to mitochondrial stress. Furthermore, since heteroplasmy development is time-dependent, the selection of a pediatric group might obscure differences that are present in later life. In addition, our analysis is restricted to a subset (n ¼ 138) of total mitochondrial variation. Finally, limiting our analysis to common childhood obesity, whereas excluding syndromic forms or BMI 43 s.d. from the mean may have failed to detect associations with other rarer forms of obesity.
Because of its central role in regulating energy production from diet, the mitochondrial genome could have a role in pediatric obesity. However, we have not identified significant differences in mitochondrial heteroplasmy or genotype between obese and lean children, making it unlikely that mitochondrial genetics has a substantial role in the pathogenesis of common childhood obesity.
